logo

FDA Calendar

Share
Company Name Y-mAbs Therapeutics, Inc.
Drug Name Danyelza (BLA)
Event Name FDA decision on Danyelza for the treatment of patients with relapsed/refractory high-risk neuroblastoma
Event Date 11/30/2020
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar